Article citationsMore>>

Reich, K., Armstrong, A.W., Langley, R.G., Flavin, S., Randazzo, B., Li, S. and Blauvelt, A. (2019) Guselkumab versus Secukinumab for the Treatment of Moderate-to-Severe Psoriasis (ECLIPSE): Results from a Phase 3, Randomized Controlled Trial. The Lancet, 394, 831-839.
https://doi.org/10.1016/S0140-6736(19)31773-8

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top